Premier clubs feel the pressure

Article Abstract:

A number of the UK's leading football clubs have seen a sharp fall in their merchandise sales. This is placing the clubs under strong financial pressure as wage bills and transfer fees rise. Football clubs are now facing a watershed as they adapt to new accounting methods and the government prepares to announce its decision on satellite television group BSkyB's 620 million pounds sterling bid for Manchester United. This club has already been forced to increase ticket prices by 14% to pay the wages of its leading players.

Comment:

Has reported that UK soccer teams are witnessing decline in merchandise sales

Sales & consumption, Cable Television Systems, Cable Networks, Sports Teams and Clubs, Professional Soccer, Finance, Cable television broadcasting industry, Cable television, British Sky Broadcasting Group PLC, Football teams, Sports franchises

---

Drug firms demand right to advertise

Article Abstract:

The blanket ban in Europe on the advertising of medicines on television and in newspapers is likely to come under significant pressure as SmithKline Beecham (SKB) prepares to receive regulatory approval in the US for Avandia, its new diabetes treatment. SKB is expected to support the launch of Avandia in the US, where drug advertising is permitted, with a high-profile media campaign. There are concerns that direct-to-consumer advertising in Europe would lead to significant pressure on social security and health budgets.

Comment:

Has reported introduction of Avandia, its new diabetes treatment drug, after anticipated regulatory approval

Europe, Government regulation, Company Planning/Goals, TV Advertising, Media Representatives, Advertising, Strategic alliances, Product introduction, Television advertising, SmithKline Beecham Corp. (Philadelphia, Pennsylvania), Marketing industry

---

Has Zeneca chosen wisely?

Article Abstract:

The planned 48 billion pounds sterling merger of Swedish pharmaceutical concern Astra with UK counterpart Zeneca will create the third-largest drug manufacturer in the world. Some observers are raising doubts about whether this deal will be entirely beneficial for Zeneca, which has for many years emphasized the benefits of independence. Astra is the manufacturer of the anti-ulcer treatment Losec, the world's best-selling prescription drug, but has also experienced a number of failures.

Comment:

Has reported that its merger of Astra AB will form world's third-largest drug manufacturer

Sweden, Pharmaceutical Preparation Manufacturing, Pharmaceutical preparations, Drugs, Organizational nomenclature, Antiulcer Preps ex Antacids, Mergers, acquisitions and divestments, Astra AB, Antiulcer agents, Zeneca Ltd.

Similar abstracts:

• Abstracts: Funds for the future. Doing the bright thing. Take a principled position in stocks
• Abstracts: Rothermere: in a class of his own. Rothermere, the last press baron, is dead. Viscount Rothermere
• Abstracts: Learning how to be the boss. Cross the channel and think international. So, is the cheque in the postgrad?
• Abstracts: No wonder the PM looks so tired, he's running a one-man show
• Abstracts: Should the central banks kill the bull markets? ECB asserts its independence. ECB gets off to a very strong start

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.